Anthera Pharmaceuticals (ANTH) Promotes Dr. Debra Odink as CTO
Tweet
Share
E-mailGet Alerts ANTH Hot Sheet
Join SI Premium – FREE
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) announced Dr. Debra Odink has been promoted to the role of Chief Technology Officer and Senior Vice President.
Dr. Odink joined Anthera in 2005 and has been serving as the Senior Vice President of Pharmaceutical Research and Development since that date. She has over eighteen years of global pharmaceutical chemistry and product development experience. Prior to joining Anthera, she served as the Vice President of Product and Process Development at Peninsula Pharmaceuticals.
Dr. Odink joined Anthera in 2005 and has been serving as the Senior Vice President of Pharmaceutical Research and Development since that date. She has over eighteen years of global pharmaceutical chemistry and product development experience. Prior to joining Anthera, she served as the Vice President of Product and Process Development at Peninsula Pharmaceuticals.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Newmark Group CEO Barry Gosin to step down at year end
- Nature's Sunshine names Ruth Perkins as new CFO, effective Sept. 1
- Zeta Global names Leah Pope as CMO, effective August 2026
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
